UFP Technologies (UFPT) | Stock Overview & Key Data
UFP Technologies Performance Comparison
Stock Range
Today's Range
Low: $215.97
High: $224.36
on August 21, 2025
52 Week Range
Low: $178.26
High: $366.41
on April 7, 2025
on September 23, 2024
All-Time High: $366.41 on September 23, 2024
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$1.7B
EPS
8.63
P/E Ratio (TTM)
25.19
Forward P/E
25.34
P/B Ratio
4.35
PEG Ratio
0.97
Div. Yield
N/A
ROE
19.29%
Beta
1.136
Debt to Equity
46.98
Financial Highlights
Profitability
Gross Margin
28.80%
Operating Margin
16.45%
Profit Margin
11.40%
Returns and Earnings
Return on Assets (TTM)
11.53%
Return on Equity (TTM)
19.29%
EBITDA
$115.6M
Net Income (TTM)
$67.1M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$76.67
Quarterly Revenue Growth (YoY)
37.20%
Quarterly Earnings Growth (YoY)
26.80%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| UFP Technologies UFPT | 1.68B Small-cap | -1.98% | -3.21% | -4.21% | -13.75% | -10.83% | -34.79% | 128.71% | 421.40% |
| Abbott Laboratories ABT | 229.31B Mega-cap | 2.10% | 6.09% | -0.79% | -2.16% | 16.36% | 17.14% | 29.54% | 19.14% |
| Boston Scientific BSX | 153.73B Large-cap | 1.02% | 1.38% | 0.54% | 0.69% | 17.71% | 32.89% | 159.65% | 156.42% |
| QuidelOrtho QDEL | 1.78B Small-cap | -1.12% | 1.42% | -13.25% | -36.58% | -43.03% | -42.99% | -68.73% | -84.25% |
| Enovis ENOV | 1.69B Small-cap | 2.36% | 12.17% | -8.81% | -30.93% | -33.41% | -35.91% | -43.59% | -48.99% |
| Conmed CNMD | 1.69B Small-cap | 0.82% | 10.93% | -7.56% | -13.19% | -21.20% | -26.24% | -42.25% | -38.83% |
Ownership & Short Interest
Insider Ownership
3.73%
Institutional Ownership
119.17%
Shares Short
1M
Short Ratio
15.31
Short % of Shares Outstanding
22.01%
Average 10-Day Volume
131K
Average 90-Day Volume
107K
UFP Technologies Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in UFP Technologies would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is UFPT's 52-week high and low?
- In the last 52 weeks, UFP Technologies reached a high of $366.41 (on September 23, 2024) and a low of $178.26 (on April 7, 2025).
- What is the market cap and P/E ratio for UFPT?
- Curious about UFP Technologies's size and valuation? Its market capitalization stands at 1.68B. When it comes to valuation, the P/E ratio (trailing twelve months) is 25.19, and the forward P/E (looking ahead) is 25.34.
- Does UFPT pay dividends? If so, what's the yield?
- As for dividends, UFP Technologies isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are UFP Technologies's main competitors or similar companies to consider before investing?
When looking at UFP Technologies, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT229.31B Healthcare Medical Devices 17.14% 29.54% Boston Scientific
BSX153.73B Healthcare Medical Devices 32.89% 159.65% QuidelOrtho
QDEL1.78B Healthcare Medical Devices -42.99% -68.73% Enovis
ENOV1.69B Healthcare Medical Devices -35.91% -43.59% Conmed
CNMD1.69B Healthcare Medical Devices -26.24% -42.25% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for UFP Technologies Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of UFP Technologies's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 19.29%, the Debt to Equity ratio from the most recent quarter is 46.98, and its Gross Profit Margin stands at 28.80%.
- What is the recent revenue and earnings growth for UFPT?
- Looking at UFP Technologies's growth, its revenue over the trailing twelve months (TTM) was $589M. Compared to the same quarter last year (YoY), quarterly revenue grew by 37.20%, and quarterly earnings saw a YoY growth of 26.80%.
- How much of UFPT stock is held by insiders and institutions?
- Wondering who owns UFP Technologies stock? Company insiders (like executives and directors) hold about 3.73% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 119.17%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.